First-Line Camizestrant for Emerging ESR1 -Mutated Advanced Breast Cancer. (2025) Bidard FC, Mayer EL, Park YH, Janni W, Ma C, Cristofanilli M, Bianchini G, et al. Journal article Malnutrition in Older Adults (2025) Cruz-Jentoft AJ, Volkert D Journal article, Review article Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer (2025) Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, Utzolino S, et al. Journal article Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer (2025) Geyer CE, Untch M, Huang CS, Mano MS, Mamounas EP, Wolmark N, Rastogi P, et al. Journal article Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease. (2025) Herrington WG, Staplin N, Agrawal N, Wanner C, Green JB, Hauske SJ, Emberson JR, et al. Journal article Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma. (2025) Wolchok JD, Chiarion-Sileni V, Rutkowski P, Cowey CL, Schadendorf D, Wagstaff J, Queirolo P, et al. Journal article Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer (2024) Schmid P, Cortes J, Dent R, Mcarthur H, Pusztai L, Kümmel S, Denkert C, et al. Journal article Magnesium Disorders (2024) Manger B, Schett G Journal article, Letter Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes (2024) Perkovic V, Tuttle KR, Rossing P, Mahaffey KW, Mann JF, Bakris G, Baeres FM, et al. Journal article